LAS VEGAS, NEV. – The Nevada State Legislature passed Assembly Bill 155 as the 82nd legislative session adjourned, Monday. The bill establishes provisions for biomarker testing in Nevada but falls short of ensuring broader patient access to needed testing. While the American Cancer Society Cancer Action Network (ACS CAN) appreciates lawmakers’ recognition of the growing importance of biomarker testing in the treatment of cancer and other conditions, this bill was significantly weakened from its original intent.
Access to Biomarker Testing Press Releases
ALBANY, NY – JUNE 5, 2023 – This afternoon, the New York State Senate passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it.
Texas Becomes Latest State to Improve Access to Biomarker Testing, Beating New York in Push to Prioritize Precision Medicine
AUSTIN, TX – MAY 30, 2023 – Yesterday, Texas Governor Greg Abbott signed Senate Bill 989 into law, making Texas the 11th state to expand access to biomarker testing. New York is considering comparable legislation through Assembly Bill 1673 / Senate Bill 1196.
Governor Walz Signs Legislation to Increase Access to Innovative Testing that Can Match Patients with Most Effective Treatments
SAINT PAUL, Minn. – Today, Governor Tim Walz signed legislation that will ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it.
Advocates Call for Senate Vote on Biomarker Testing Legislation, Citing Importance of Precision Medicine in Innovation
ALBANY, NY – MAY 19, 2023 – Every year on May 20, patients and providers celebrate the invaluable work of clinical trials in the effort to eradicate all suffering and death from cancer.
Oncologists Call for Improvements in Access to Biomarker Testing as Assembly Insurance Committee Signals Unanimous Support
ALBANY, NY – MAY 17, 2023 – Earlier today, oncologists and cancer survivors from across New York gathered at the Capitol to answer lawmakers’ questions about biomarker testing and ask for their support of Senate Bill 1196 / Assembly Bill 1673. This legislation, which is being sponsored by Asm.
The American Cancer Society Cancer Action Network Thanks Lawmakers for Passing Legislation That Expands Access to Precision Medicine.
Oncologists to Visit New York State Capitol & Urge Legislators to Improve Access to Biomarker Testing
ALBANY, NY – MAY 15, 2023 – Oncologists and cancer survivors from across New York will gather at the Capitol building on Wednesday, May 17 to answer lawmakers’ questions about biomarker testing and ask for their support of Senate Bill 1196 / Assembly Bill 1673, which aim to improve New Yorkers’ a
ATLANTA, GA – MAY 1, 2023 – Tomorrow, Gov. Brian Kemp will hold a ceremonial bill signing for legislation that will increase insurance coverage for biomarker testing – thus making this form of precision medicine available to more Georgians.